EXPERT COMMENTARIES

Professor Gary Lewis, Director of the Banting and Best Diabetes Centre at the University of Toronto, Canada, and co-author of the report discusses the evidence presented in this important publication and its implications for clinicians and patients.

Dr Michael Miller, Professor of Cardiovascular Medicine at the University of Maryland, Baltimore, USA, explains that the ACC’s expert consensus decision pathway stratifies patients with atherosclerotic cardiovascular disease (ASCVD) and persistent hypertriglyceridaemia according to their residual LDL-cholesterol (LDL-C) level.